Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot feasibility study of Ferinject in operable esophageal cancer with iron deficiency anemia
NL-OMON37387Withdrawn
- Sponsor
- Amsterdam University Medical Center
- Start
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of ferric carboxymaltose in iron deficiency anemia (IDA), sponsored by Amsterdam University Medical Center. Primary endpoints: Number of hemoglobin responders and Serious adverse events of Ferinject. Planned start Sep 2012; status: withdrawn.
02
Drugs
ferric carboxymaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NL-OMON37387.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37387.